iBio
IBIO
#9755
Rank
NZ$86.25 M
Marketcap
NZ$3.84
Share price
9.52%
Change (1 day)
-31.74%
Change (1 year)

Market capitalization of iBio (IBIO)

Market cap: NZ$86.25 Million

As of February 2026 iBio has a market cap of NZ$86.25 Million. This makes iBio the world's 9755th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of iBio from 2008 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$86.25 M17.54%
2025NZ$73.38 M84.63%
2024NZ$39.74 M815.07%
2023NZ$4.34 M-31.07%
2022NZ$6.3 M-96.4%
2021NZ$0.17 B-43.15%
2020NZ$0.30 B1427.5%
2019NZ$20.17 M-4.64%
2018NZ$21.15 M-26.43%
2017NZ$28.75 M-43.41%
2016NZ$50.81 M-19.69%
2015NZ$63.26 M0.54%
2014NZ$62.93 M139.55%
2013NZ$26.27 M-27.03%
2012NZ$36 M4.54%
2011NZ$34.43 M-73.96%
2010NZ$0.13 B277.55%
2009NZ$35.03 M725.42%
2008NZ$4.24 M

End of Day market cap according to different sources

On Feb 1st, 2026 the market cap of iBio was reported to be:

NZ$78.75 Million
by Nasdaq info icon info icon
NZ$78.75 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$927.20 B 1,074,795.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Genocea Biosciences
GNCA
NZ$0 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
NZ$1.29 B 1,399.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$1.04 B 1,107.91%๐Ÿ‡บ๐Ÿ‡ธ USA